http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PE-20081266-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69ece09bafee7e0c49d1f7951a3faa2c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-515
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-1045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3069
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2007-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e5db01313277e6aba5bf15073fc123c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a4831b72d6117d0e16f69868591a370
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d981dfb313ba5ed7e2fa4284e5792fdc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_878d6e1a1d0c532d5a802cdec2919b88
publicationDate 2008-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PE-20081266-A1
titleOfInvention ANTIBODIES AND IMMUNOCONJUGATES
abstract REFERRED TO AN ANTIBODY THAT JOINS STEAP-1 (SIX TRANSMEMBRANE EPITHELIAL ANTIGENS OF THE PROSTATE) INCLUDING ONE, TWO OR THREE HYPERVARIABLE HEAVY-CHAIN REGIONS (HVR) SELECTED FROM: 1) A HVR-H1 SEQUENCE CONTAINING AMINO ACIDS OF SEQUENCE IDENTIFIER NO. 14, 2) AN HVR-H2 CONTAINING THE AMINO ACID SEQUENCE OF SEQUENCE IDENTIFIER NO. 15 AND 3) AN HVR-H3 CONTAINING THE AMINO ACID SEQUENCE OF SEQUENCE IDENTIFIER NO. 16. ALSO REFERRED TO THIS AN IMMUNOCONJUGATE THAT INCLUDES AN ANTIBODY THAT COVALENTLY JOINES A CYTOTOXIC AGENT SUCH AS A TOXIN, A CHEMOTHERAPEUTIC AGENT, A FRACTION OF A PHARMACO, AN ANTIBIOTIC, AMONG OTHERS, WHERE SAID ABUSED FORM IS IMMUNOUSLY. THE DESCRIBED ANTIBODY, L IS A BINDER SUCH AS-6-PHENYLALANINE, VALINE-CITRULINE, MALEIMIDOPROPANOIL, AMONG OTHERS, AND D IS A FRACTION OF A DRUG SUCH AS AURISTATIN AND DOLASTATIN
priorityDate 2006-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85286805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422602897

Total number of triples: 46.